Added To 600,000 Tests, YHLO And C-Mer Donated COVID-19 Antigen Tests To Hong Kong Again

Shenzhen YHLO and its Hong Kong partner, Hong Kong C-Mer (C-Mer Eye Care Holdings Limited), announced that they donated once again to the Hong Kong society on February 22, after the donation of 300,000 YHLO COVID-19 Rapid Antigen Tests to the Hong Kong on February 16. The total number of the donations increased to 600,000 tests. YHLO and C-Mer are joining hands to help Hong Kong citizens to fight against COVID-19.

More information

Details

Bao Long Da Dao & Bao Long Er Lu, Long Gang Qu, Shen Zhen Shi, Guang Dong Sheng, China, 518118

YHLO

Associated Trend items

Breaking news! YHLO received FDA 510(k) clearance

YHLO iFlash 3000-C Chemiluminescence Analyzer and HCG Test Kit have received FDA 510(k) clearance. It is YHLO’s first 100% independently cleared by FDA.

Recently, YHLO iFlash 3000-C Chemiluminescence Analyzer and HCG Test Kit have received FDA 510(k) clearance. It is YHLO’s first 100% independently cleared by FDA. FDA clearance for In Vitro Diagnostic (IVD) products is a crucial regulatory step in the United States. When the FDA clears an IVD product, it means that the product has undergone a thorough evaluation and sign...

More information

YHLO Newest IVDR Certificate Extended to 72 Products

In August 2022, YHLO received the newest IVDR Certificate from BSI, one of the most reputable notified bodies for medical device CE certifications.

The IVDR certificate of YHLO covers additional 58 YHLO chemiluminescent immunoassay (CLIA) detection products including TSH, Cardiolipin IgG, AMH, CA 15-3, CK-MB, HSV-1 IgG etc. Until today, YHLO has obtained IVDR CE Certificate of 72 products, covering the autoimmunity, reproductive health, tumor markers, cardiac markers, infection detection fields and so forth. The Re...

More information

YHLO's National-level Key Project Officially Launched

The "R&D of High-performance Immune On-site Rapid Diagnosis System" project is an important part of the key special task of "Diagnostic and Treatment Equipment and Biomedical Materials" of the Chinese National Key R&D Plan.

On December 16th, YHLO in collaboration with Professor Zhou Zhou from Fuwai Hospital of the Chinese Academy of Medical Sciences, has taken the lead in the initiation of the "R&D of High-performance Immune On-site Rapid Diagnosis System" project. Aligned with the "Diagnostic Devices and Biomedical Materials" key task of the Chinese National Key R&D Program, this project a...

More information

Compare

Remove all

Compare up to 10 products